Substitution Scanning Identifies a Novel, Catalytically Active Ibrutinib-Resistant BTK Cysteine 481 to Threonine (C481T) Variant

Leukemia - United Kingdom
doi 10.1038/leu.2016.153
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Expanding Horizons in the Treatment of Mantle Cell Lymphoma: Ibrutinib a Novel BTK-targeting Inhibitor

International Journal of Basic & Clinical Pharmacology
2014English

Lacticin 481 Synthetase as a General Serine/Threonine Kinase

ACS Chemical Biology
BiochemistryMedicineMolecular Medicine
2009English

BTK Inhibitor Ibrutinib in CLL and Mantle Cell Lymphoma

Community Oncology
2013English

Novel Chemotherapy-Free Combination Regimen for Ibrutinib-Resistant Mantle Cell Lymphoma

British Journal of Haematology
Hematology
2017English

Synthetic Access to 3Substituted Pyroglutamic Acids From Tetramate Derivatives of Serine, Threonine, Allo-Threonine, and Cysteine

English

Structural Prediction of the Interaction of the Tumor Suppressor P27KIP1 With Cyclin a/Cdk2 Identifies a Novel Catalytically Relevant Determinant

BMC Bioinformatics
BiochemistryApplied MathematicsComputer Science ApplicationsStructural BiologyMolecular Biology
2017English

RNA Conformation in Catalytically Active Human Telomerase

Journal of the American Chemical Society
BiochemistryColloidCatalysisChemistrySurface Chemistry
2010English

Routes Towards Catalytically Active TiO2doped Porous Cellulose

RSC Advances
ChemistryChemical Engineering
2015English

Multiscale Modeling to Investigate Catalytically Active Enzymatic Aggregates for Cascade Bioreactions

Chemie-Ingenieur-Technik
ChemistryChemical EngineeringManufacturing EngineeringIndustrial
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy